According to AnaptysBio's latest financial reports the company's current earnings (TTM) are -$0.15 B. In 2022 the company made an earning of -$0.11 B a decrease over its 2021 earnings that were of -$55.95 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.15 B | 35.27% |
2022 | -$0.11 B | 92.31% |
2021 | -$55.95 M | 137.28% |
2020 | -$23.58 M | -75.55% |
2019 | -$96.45 M | 60.22% |
2018 | -$60.2 M | 112.74% |
2017 | -$28.3 M | 644.41% |
2016 | -$3.81 M | -20.91% |
2015 | -$4.81 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | -23.88% | ๐บ๐ธ USA |